Cargando…

Pan-Cancer analysis and experimental validation identify the oncogenic nature of ESPL1: Potential therapeutic target in colorectal cancer

INTRODUCTION: Extra spindle pole bodies like 1 (ESPL1) are required to continue the cell cycle, and its primary role is to initiate the final segregation of sister chromatids. Although prior research has revealed a link between ESPL1 and the development of cancer, no systematic pan-cancer analysis h...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhong, Yuchen, Zheng, Chaojing, Zhang, Weiyuan, Wu, Hongyu, Wang, Meng, Zhang, Qian, Feng, Haiyang, Wang, Guiyu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10060535/ https://www.ncbi.nlm.nih.gov/pubmed/37006282 http://dx.doi.org/10.3389/fimmu.2023.1138077

Ejemplares similares

Short-term and long-term outcomes of natural orifice specimen extraction surgeries (NOSES) in rectal cancer: a comparison study of NOSES and non-NOSES
por: Zhang, Qian, et al.
Publicado: (2022)

DEF6 has potential to be a biomarker for cancer prognosis: A pan-cancer analysis
por: Yuan, Ziming, et al.
Publicado: (2023)

ESPL1 is Elevated in Hepatocellular Carcinoma and Predicts Prognosis
por: Song, Rui, et al.
Publicado: (2022)

TTK, CDC25A, and ESPL1 as Prognostic Biomarkers for Endometrial Cancer
por: Yang, Qiannan, et al.
Publicado: (2020)

ESPL1 Is a Novel Prognostic Biomarker Associated With the Malignant Features of Glioma
por: Liu, Zhendong, et al.
Publicado: (2021)

circ-0000212 promotes cell proliferation of colorectal cancer by sponging miR-491 and modulating FOXP4 expression
por: Wu, Hongyu, et al.
Publicado: (2021)

A Pan-Cancer Analysis of the Oncogenic Role of Cell Division Cycle-Associated Protein 4 (CDCA4) in Human Tumors
por: Fang, Hui, et al.
Publicado: (2022)

Systematic Pan-Cancer Analysis Identifies TREM2 as an Immunological and Prognostic Biomarker
por: Cheng, Xin, et al.
Publicado: (2021)

Comprehensive Pan-Cancer Analysis of IRAK Family Genes Identifies IRAK1 as a Novel Oncogene in Low-Grade Glioma
por: Li, Jing, et al.
Publicado: (2022)

NEPdb: A Database of T-Cell Experimentally-Validated Neoantigens and Pan-Cancer Predicted Neoepitopes for Cancer Immunotherapy
por: Xia, Jiaqi, et al.
Publicado: (2021)

Integrated pan-cancer analysis and experimental verification of the roles of tropomyosin 4 in gastric cancer
por: Guo, Qijing, et al.
Publicado: (2023)

Genome-wide discovery of circulating cell-free DNA methylation biomarkers for colorectal cancer detection
por: Fang, Qingxiao, et al.
Publicado: (2023)

Pan-Cancer Analysis and Experimental Validation Identify ACOT7 as a Novel Oncogene and Potential Therapeutic Target in Lung Adenocarcinoma
por: Zheng, Chao, et al.
Publicado: (2022)

CircSTK3 drives the metastasis of colorectal cancer by regulating epithelial-mesenchymal transition
por: Fan, Boyang, et al.
Publicado: (2023)

Individualized pathway activity algorithm identifies oncogenic pathways in pan-cancer analysis
por: Ke, Xin, et al.
Publicado: (2022)

Pan-cancer analysis identifies PD-L2 as a tumor promotor in the tumor microenvironment
por: Lv, Jingfang, et al.
Publicado: (2023)

Pan-cancer characterization of immune-related lncRNAs identifies potential oncogenic biomarkers
por: Li, Yongsheng, et al.
Publicado: (2020)

Pan-cancer analyses identify DCBLD2 as an oncogenic, immunological, and prognostic biomarker
por: Xie, Pan, et al.
Publicado: (2022)

Identify the immune characteristics and immunotherapy value of CD93 in the pan-cancer based on the public data sets
por: Guo, Aiyuan, et al.
Publicado: (2022)

Systematic pan-cancer analysis identifies CDC45 as having an oncogenic role in human cancers
por: Lu, Yalin, et al.
Publicado: (2022)

Analysis and Experimental Validation of Rheumatoid Arthritis Innate Immunity Gene CYFIP2 and Pan-Cancer
por: Zhao, ZhenYu, et al.
Publicado: (2022)

Integrated bioinformatic analysis identified a novel prognostic pan-programmed cell death signature for bladder cancer
por: Zhang, Lusi, et al.
Publicado: (2022)

Pan-cancer analyses of classical protein tyrosine phosphatases and phosphatase-targeted therapy in cancer
por: Wang, Tao, et al.
Publicado: (2022)

Molecular Characteristics, Oncogenic Roles, and Relevant Immune and Pharmacogenomic Features of EVA1B in Colorectal Cancer
por: Ma, Bin, et al.
Publicado: (2022)

Prognostic Implication and Oncogenic Role of PNPO in Pan-Cancer
por: Zhang, Lingyun, et al.
Publicado: (2022)

Homeobox oncogene activation by pan-cancer DNA hypermethylation
por: Su, Jianzhong, et al.
Publicado: (2018)

An Integrated Analysis Identified TAGLN2 As an Oncogene Indicator Related to Prognosis and Immunity in Pan-Cancer
por: Pan, Teng, et al.
Publicado: (2023)

Pan-cancer analysis identifies the correlations of Thymosin Beta 10 with predicting prognosis and immunotherapy response
por: Li, Zhanzhan, et al.
Publicado: (2023)

Pan-Cancer Analysis of Oncogenic Role of RAD54L and Experimental Validation in Hepatocellular Carcinoma
por: Zhou, Yongzhen, et al.
Publicado: (2023)

MMTV-Espl1 Transgenic Mice Develop Aneuploid, Estrogen Receptor Alpha (ERα)-Positive Mammary Adenocarcinomas
por: Mukherjee, Malini, et al.
Publicado: (2013)

Serum ESPL1 Can Be Used as a Biomarker for Patients With Hepatitis B Virus-Related Liver Cancer: A Chinese Case-Control Study
por: Wang, Rongming, et al.
Publicado: (2020)

Prognostic impact of increased lymph node yield in colorectal cancer patients with synchronous liver metastasis: a population-based retrospective study of the US database and a Chinese registry
por: Jiao, Shuai, et al.
Publicado: (2023)

A Comprehensive Analysis of METTL1 to Immunity and Stemness in Pan-Cancer
por: Gao, Zijie, et al.
Publicado: (2022)

Clinical Implications of Necroptosis Genes Expression for Cancer Immunity and Prognosis: A Pan-Cancer Analysis
por: Li, Xin-yu, et al.
Publicado: (2022)

A Pan-Cancer Analysis of SMARCA4 Alterations in Human Cancers
por: Peng, Ling, et al.
Publicado: (2021)

c-MYB is a transcriptional regulator of ESPL1/Separase in BCR-ABL-positive chronic myeloid leukemia
por: Prinzhorn, Wiltrud, et al.
Publicado: (2016)

EspL is essential for virulence and stabilizes EspE, EspF and EspH levels in Mycobacterium tuberculosis
por: Sala, Claudia, et al.
Publicado: (2018)

Exploring the oncogenic roles of LINC00857 in pan-cancer
por: Ren, Xiaomin, et al.
Publicado: (2022)

Systematic pan-cancer analysis identifies RALA as a tumor targeting immune therapeutic and prognostic marker
por: Jin, Haoer, et al.
Publicado: (2022)

Pan-Cancer Analysis of Immune Cell Infiltration Identifies a Prognostic Immune-Cell Characteristic Score (ICCS) in Lung Adenocarcinoma
por: Zuo, Shuguang, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_49o54bc191g1vj662imumat9jv